Cancer Drug Resistance Predicted by CRISPR Screens – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Cancer Drug Resistance Predicted by CRISPR Screens
Genetic Engineering & Biotechnology News Scientists at the Institute of Cancer Research (ICR) in the U.K. have harnessed CRISPR-Cas9 genome-editing technology to uncover why some tumors are resistant to poly(ADP-ribose) polymerase inhibitors (PARPi), such as olaparib and talazoparib. |
